Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Equity Average (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Equity Average for 12 consecutive years, with $20.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average fell 48.62% year-over-year to $20.8 million, compared with a TTM value of $20.8 million through Sep 2025, down 48.62%, and an annual FY2024 reading of $41.7 million, down 3.25% over the prior year.
  • Equity Average was $20.8 million for Q3 2025 at Sanara MedTech, down from $36.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $44.3 million in Q4 2023 and bottomed at $20.7 million in Q1 2021.
  • Average Equity Average over 5 years is $36.8 million, with a median of $39.2 million recorded in 2024.
  • The sharpest move saw Equity Average skyrocketed 509.11% in 2021, then plummeted 48.62% in 2025.
  • Year by year, Equity Average stood at $31.8 million in 2021, then soared by 35.85% to $43.2 million in 2022, then rose by 2.68% to $44.3 million in 2023, then decreased by 11.64% to $39.2 million in 2024, then tumbled by 46.99% to $20.8 million in 2025.
  • Business Quant data shows Equity Average for SMTI at $20.8 million in Q3 2025, $36.0 million in Q2 2025, and $37.8 million in Q1 2025.